Paula PerezSanchez Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Biography and Research Information
OverviewAI-generated summary
Paula PerezSanchez researches the use of plants as biofactories for producing therapeutic proteins and antiviral compounds. Her work investigates the genetic modification of plants and plant cells to express specific proteins, such as endoglucanase from Acidothermus cellulolyticus. This research explores the post-translational modifications these proteins undergo, including hydroxyproline-O-glycosylation, and their impact on the digestibility of biomass. PerezSanchez also examines strategies to enhance protein production within plant systems, addressing challenges in plant cell-based production. Her scholarship metrics include an h-index of 2, with 3 total publications and 29 total citations. Key collaborators at Arkansas State University include Jianfeng Xu, Corbin England, Jonathan TrejoMartinez, and Jacqueline Vargas Ulloa.
Metrics
- h-index: 2
- Publications: 3
- Citations: 30
Selected Publications
-
Unlocking the full potential of plant cell-based production for valuable proteins: Challenges and innovative strategies (2025)
-
Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility (2024)
-
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19 (2023)
Collaboration Network
Top Collaborators
- Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
- Unlocking the full potential of plant cell-based production for valuable proteins: Challenges and innovative strategies
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
- Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
- Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Unlocking the full potential of plant cell-based production for valuable proteins: Challenges and innovative strategies
Similar Researchers
Based on overlapping research topics